NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- Status
- RECRUITING
- Phase
- PHASE2
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Imvotamab Monotherapy and in Combination in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers
- Status
- TERMINATED
- Phase
- NA
Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health
- Status
- COMPLETED
- Phase
- NA
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Improving Exercise Capacity With Tailored Physical Activity in Lymphoma & Breast Cancer Patients Undergoing Tx
- Status
- COMPLETED
- Phase
- NA
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
- Status
- COMPLETED
- Phase
- NA
Copanlisib in Combination With Venetoclax in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.
- Status
- TERMINATED
- Phase
- PHASE1
VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study of ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1